Fig. 2From: A systematic classification of megakaryocytic dysplasia and its impact on prognosis for patients with myelodysplastic syndromes a Survival of 370 subjects with micro-megakaryocyte <25 or ≥25 %; b Survival of subjects with dysplastic mono-nucleated megakaryocytes <30 or ≥30 %Back to article page